The present invention relates to amide containing aromatic MMP inhibiting compounds with a mono-amide heteroaromatic group, of formulas I and II:
本发明涉及具有含芳香族MMP抑制化合物的酰胺,其具有单酰胺杂芳基团,化学式I和II:
An improved method for the synthesis of substituted cyclobutenediones
作者:Lanny S. Liebeskind、Richard W. Fengl、Kevin R. Wirtz、Thomas T. Shawe
DOI:10.1021/jo00246a017
日期:1988.5
<i>tert</i>-Butyl Substituent as a Regiodirecting and Novel C−H Protecting Group in Cyclobutenedione-Based Benzannulation Chemistry
作者:Fuqiang Liu、Lanny S. Liebeskind
DOI:10.1021/jo971565p
日期:1998.5.1
2-Unsubstituted hydroquinone monoacetates, quinones, and 3-unsubstituted quinolizinones were synthesized in moderate to high yields via tert-butyl and trimethylsilyl substituted cyclobutenediones. The addition of unsaturated carbon nucleophiles proceeded regiospecifically at the carbonyl group most distant from the tert-butyl or trimethylsilyl substituent. Thermolysis of the adducts, followed by treatment under acidic conditions to remove the tert-butyl and trimethylsilyl groups in good overall yields, provided access to a variety of "less-substituted" hydroquinone monoacetates, quinones, and quinolizinones. Of the two systems, the tert-butyl-substituted cyclobutenediones proved the most useful.
LIEBESKIND, LANNY S.;FENGL, RICHARD W.;WIRTZ, KEVIN R.;SHAWE, THOMAS T., J. ORG. CHEM., 53,(1988) N 11, C. 2482-2488
作者:LIEBESKIND, LANNY S.、FENGL, RICHARD W.、WIRTZ, KEVIN R.、SHAWE, THOMAS T.
DOI:——
日期:——
KISSPEPTIDE-PENTASACCHARIDE CONJUGATES
申请人:Blomenrohr Marion
公开号:US20140206627A1
公开(公告)日:2014-07-24
The invention relates to kisspeptide-pentasaccharide conjugates having the general formula (I) wherein Z
1
is Tyr or D-Tyr; Z
3
is Trp, Hyp, Phe or Lys(R
2
); Z
5
is Thr, Aib or Ala; Z
7
is Gly or azaGly; Z
8
is Leu; or Z
7
and Z
8
together represent; Z
10
is Phe or Trp; n is 0 or 1; or R
2
, when present, represents a pentasaccharide derivative having the formula (II) wherein R is methyl or SO
3
X; X is a positively charged counterion; with the proviso that when R
2
is present, R
1
is H or (C
1-6
) alkylcarbonyl; R
3
is H or (C
1-3
)alkyl; and L represents a pharmacologically inactive linker moiety having 10-50 atoms; or a pharmaceutically acceptable salt thereof; to pharmaceutical compositions comprising the same as well as to the use of said kisspeptide-pentasaccharide conjugates in the treatment of female infertility.